Tech Company Financing Transactions
Alveolus Funding Round
On 9/22/2008, Alveolus raised $3 million in Series E funding from private investors.
Transaction Overview
Company Name
Announced On
9/22/2008
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series E
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
9013 Perimeter Woods Suite A
Charlotte, NC 28216
USA
Charlotte, NC 28216
USA
Phone
Website
Email Address
Overview
Alveolus is an emerging leader in the development of non-vascular interventional stent technology. Alveolus' advanced stenting technology is designed to enhance the quality of life for patients who suffer from malignant pulmonary and gastrointestinal obstructive lumen diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Chazanovitz
Chief Financial Officer
Michael Reid
VP - Operations
Richard Snider
VP - Sales
Todd Martensen
Browse more venture capital transactions:
Prev: 9/22/2008: 3Leaf Networks venture capital transaction
Next: 9/22/2008: Daylight Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs